Impact
Gil Atzmon is a geneticist whose work centres on how the genome and epigenome relate to disease, health and exceptional longevity, with a long-running focus on centenarians and Ashkenazi Jewish cohorts. Trained in population genetics at the Hebrew University, he completed a fellowship in human genetics at Albert Einstein College of Medicine and rose to associate professor there before joining the University of Haifa, where he is a full professor in the Department of Human Biology and works on epigenetics and genomics of ageing. His most-cited ageing papers, as listed on his Google Scholar profile, include reports of a distinctive lipoprotein phenotype and genotype associated with exceptional longevity (JAMA, 2003), functionally significant IGF-1 receptor mutations in centenarians (PNAS, 2008) and common variation in the insulin/IGF-1 signalling pathway associated with human longevity (Aging Cell, 2009). He also contributed to large consortium studies, including the 2014 NEJM report linking age-related clonal haematopoiesis to adverse outcomes and a meta-analysis of genome-wide association studies of longevity (Nature Communications, 2019). His 2026 publications list both the University of Haifa and the Departments of Medicine and Genetics at Albert Einstein College of Medicine.
Metrics
- h-index 74 · google scholar as of 2026-09-23 source ↗
Research output
275 works · 36,301 citations · h-index 70 OpenAlex ↗
Selected publications
- The mutational constraint spectrum quantified from variation in 141,456 humans ↗ 2020 · 10,434 citations
- Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes ↗ 2014 · 4,912 citations
- A genomic mutational constraint map using variation in 76,156 human genomes ↗ 2023 · 1,460 citations
- A structural variation reference for medical and population genetics ↗ 2020 · 1,206 citations
- The genetic architecture of type 2 diabetes ↗ 2016 · 1,129 citations